2025-03-12 12:43:25
Latest Post
W S Industries India Ltd's subsidiary to acquire 54.89 acres land for Rs. 46.66 crores
IKS Health wins Top Honors in 2025 Black Book Survey in New AI-Driven RCM Category
Mipco Seamless Rings Gujarat Ltd approves shifting of registered office
Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
REC Limited inaugurates REC Experience Center
Stock Report
Windlas Biotech Ltd reports consolidated PAT of Rs. 9.18 crores in Q3FY23
Posted On : 2023-02-08 15:59:15( TIMEZONE : IST )
Windlas Biotech Ltd has reported Consolidated financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 121.866 crores during the period ended December 31, 2022 as compared to Rs. 135.341 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. 9.188 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 12.194 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. 4.23 for the period ended December 31, 2022 as compared to Rs. 5.59 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹121.866 crs | ₹135.341 crs |  -9.96% |
| Net Profit | ₹9.188 crs | ₹12.194 crs | -24.65% |
| EPS | ₹4.23 | ₹5.59 | -24.33% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.121.866 crores during the period ended December 31, 2022 as compared to Rs.119.384 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.9.188 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.8.314 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.4.23 for the period ended December 31, 2022 as compared to Rs.3.81 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹121.866 crs | ₹119.384 crs |  2.08% |
| Net Profit | ₹9.188 crs | ₹8.314 crs | 10.51% |
| EPS | ₹4.23 | ₹3.81 | 11.02% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.380.001 crores during the 9 Months period ended December 31, 2022 as compared to Rs.347.50 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.31.182 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.23.301 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.14.33 for the 9 Months period ended December 31, 2022 as compared to Rs.11.60 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹380.001 crs | ₹347.50 crs | 9.35% |
| Net Profit | ₹31.182 crs | ₹23.301 crs | 33.82% |
| EPS | ₹14.33 | ₹11.60 | 23.53% |
Shares of Windlas Biotech Ltd was last trading in BSE at Rs. 242.15 as compared to the previous close of Rs. 241.40. The total number of shares traded during the day was 512 in over 81 trades.
The stock hit an intraday high of Rs. 249.00 and intraday low of 239.30. The net turnover during the day was Rs. 123063.00.
